Sutter appointed to Abiomed board

TriMed Staff | | Health Imaging | Artificial Intelligence
Abiomed has appointed Martin P. Sutter to its board of directors.

The company said that Sutter is one of the two founding managing directors of Essex Woodlands Health Ventures, a healthcare-focused venture capital firm with nearly $3 billion under management. Sutter has more than 30 years of management experience in operations, marketing, finance and venture capital.

Sutter currently serves on the board of directors of BioForm Medical, LaJolla Pharmaceuticals, and LifeCell, which is in the process of being acquired by Kinetic Concepts, according to the Danvers, Mass.-based Abiomed.

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.